BlockBeats said that after including Anthropic’s IPO, the total funding from US IPOs in 2026 is close to 246000000000 USD, exceeding the record set in 2021. The company’s listing may also bring additional stock supply and demand for index funds.
Iambic Therapeutics issued approximately 16 USD shares at a per-share price of 9380000, in the United States IPO IPO 150000000 USD, and is expected to trade on Nasdaq on October 15 under the ticker IAM.
According to Bloomberg,OPay plans to raise funds through the New York IPO and concurrent private placement, totaling approximately 500000000 USD with Standard Bank Group expected to participate in approximately 200000000 USD in the private placement. The plan has not been publicly disclosed.
RedotPay said it had completed its financial audit and anti-money laundering and counter-terrorist financing control reviews, and that it was continuing to advance its U.S.IPO process with its partners; no IPO date was disclosed.
U.S.September IPO IPO activity remains subdued, with multiple companies postponing their listings;August the filing expected to be submitted as early as the end of Anthropic had still not been submitted as of the time of reporting.